LSA
IONS icon

Leonteq Securities AG’s Ionis Pharmaceuticals IONS Stock Holding History

Leonteq Securities AG’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.79K Hold
73
– – ﹤0.01% 1077
2026
Q1 		$5.48K Buy
73
+10
+16% +$789 ﹤0.01% 1115
2025
Q4 		$4.98K Hold
63
– – ﹤0.01% 1252
2025
Q3 		$4.12K Hold
63
– – ﹤0.01% 1183
2025
Q2 		$2.49K Hold
63
– – ﹤0.01% 1165
2025
Q1 		$1.9K Hold
63
– – ﹤0.01% 1150
2024
Q4 		$2.2K Hold
63
– – ﹤0.01% 1153
2024
Q3 		$2.52K Buy
+63
New +$2.93K ﹤0.01% 1089
2024
Q2 		– Sell
-212
Closed -$9.19K – 1250
2024
Q1 		$9.19K Buy
+212
New +$10.1K ﹤0.01% 1027
2023
Q4 		– Sell
-130
Closed -$5.9K – 1239
2023
Q3 		$5.9K Buy
+130
New +$5.36K ﹤0.01% 1053
2023
Q2 		– Sell
-55
Closed -$1.97K – 1268
2023
Q1 		$1.97K Sell
55
-468
-89% -$17.6K ﹤0.01% 1151
2022
Q4 		$19.8K Buy
523
+209
+67% +$8.79K ﹤0.01% 968
2022
Q3 		$13.9K Sell
314
-1,640
-84% -$69.1K ﹤0.01% 1009
2022
Q2 		$72.3K Sell
1,954
-273
-12% -$10.3K ﹤0.01% 752
2022
Q1 		$82.5K Sell
2,227
-4,009
-64% -$131K ﹤0.01% 773
2021
Q4 		$190K Buy
6,236
+757
+14% +$23.8K 0.01% 635
2021
Q3 		$184K Buy
5,479
+2,282
+71% +$86K 0.01% 607
2021
Q2 		$128K Buy
3,197
+1,672
+110% +$65.5K 0.01% 669
2021
Q1 		$68.6K Sell
1,525
-1,631
-52% -$91K ﹤0.01% 750
2020
Q4 		$178K Buy
+3,156
New +$157K 0.01% 580

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Leonteq Securities AG's IONS Position: Q2 2026 in Review

Leonteq Securities AG held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 73 shares worth $5.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Leonteq Securities AG first reported a position in IONS in Q4 2020 and has held it in 20 quarters since. The position peaked at $190K in Q4 2021. 511 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Leonteq Securities AG held 73 shares of Ionis Pharmaceuticals worth $5.79K as of Q2 2026.
  • Leonteq Securities AG left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1077 holding.
  • Leonteq Securities AG first reported a position in Ionis Pharmaceuticals in Q4 2020 and has held it in 20 quarters since.
  • Leonteq Securities AG's Ionis Pharmaceuticals position peaked at $190K in Q4 2021.
  • 511 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.